Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)

Biochemical Pharmacology
E O AboagyeP Workman

Abstract

The aim of this work was to study the metabolic characteristics of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554). HPLC and 19F NMR methods were employed to evaluate the rate of reductive metabolism of SR-4554 and the nature of the resulting metabolites, respectively. SR-4554 was enzymatically reduced by mouse liver microsomes (1.1 +/- 0.1 nmol of SR-4554 reduced/min/mg protein), purified rat and human NADPH:cytochrome P450 reductase (17.8 +/- 0.4 and 5.0 +/- 0.5 nmol of SR-4554 reduced/min/mg protein, respectively), and SCCVII tumour homogenates (2.3 +/- 0.3 nmol of SR-4554 reduced/min/g tumour) under nitrogen. NADPH:cytochrome P450 reductase was a major microsomal enzyme involved in the bioreduction of SR-4554 by liver microsomes. In a panel of murine and human tumour xenografts, cytochrome P450 reductase activities were found to be low and only varied by 3-fold between different tumour types, suggesting that enzyme activities within the tumours are unlikely to influence markedly in vivo reductive metabolism. Reduction of SR-4554 by mouse liver microsomes showed a characteristic oxygen dependence with a half-maximal inhibition of 0.48 +/- 0.06...Continue Reading

References

Apr 19, 1976·Biochemical and Biophysical Research Communications·P Wardman, E D Clarke
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P Workman
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·W J KohT W Griffin
Nov 27, 1991·Biochemical Pharmacology·J L PrekegesK H Krohn
Nov 1, 1989·International Journal of Radiation Biology·J Overgaard
Apr 1, 1989·International Journal of Radiation Oncology, Biology, Physics·R J MaxwellJ R Griffiths
Apr 1, 1989·International Journal of Radiation Oncology, Biology, Physics·M I WaltonP Workman
Mar 1, 1989·International Journal of Radiation Oncology, Biology, Physics·P L Olive, R E Durand
Jul 1, 1986·International Journal of Radiation Oncology, Biology, Physics·A J Franko
Jul 1, 1986·International Journal of Radiation Oncology, Biology, Physics·J A RaleighP S Allen
Mar 1, 1968·Journal of the National Cancer Institute·L M Van Putten, R F Kallman
Mar 1, 1982·International Journal of Radiation Oncology, Biology, Physics·G G MillerJ D Chapman
Apr 1, 1981·British Journal of Cancer·P D JosephyL D Skarsgard
Jun 15, 1994·International Journal of Radiation Oncology, Biology, Physics·R RamplingP Workman
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·G C SmithC R Wolf
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·P JosephJ D Chapman
Jun 1, 1993·Cancer Metastasis Reviews·P Workman, I J Stratford

❮ Previous
Next ❯

Citations

Mar 25, 2000·European Journal of Medicinal Chemistry·M A OrtegaA Monge
Dec 9, 1998·International Journal of Radiation Oncology, Biology, Physics·D W Siemann
Oct 25, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H Anderson, P Price
Dec 17, 2003·Journal of Toxicology and Environmental Health. Part a·Fu-Chuo PengShao-Chun Lu
May 29, 1999·International Journal of Radiation Oncology, Biology, Physics·B P van der SandenA J van der Kogel
Dec 2, 2004·The British Journal of Radiology·B M Seddon, P Workman
Dec 14, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Howard W Salmon, Dietmar W Siemann
May 14, 2011·NMR in Biomedicine·Leanne K BellJohn R Griffiths
May 4, 2006·Journal of the National Cancer Institute·Paul WorkmanUNKNOWN Cancer Research UK Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee
Jan 25, 2011·NMR in Biomedicine·Jesús Pacheco-TorresSebastián Cerdán
Oct 1, 2004·The British Journal of Radiology·G R Laking, P M Price
Jun 10, 2017·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Amarnath ChallapalliEric O Aboagye
Oct 8, 2020·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Micol PasqualiAlessandra Boschi
Nov 3, 2004·Toxicology and Applied Pharmacology·Kjetil AskPhilippe Camus
Nov 30, 2005·Biochemical Pharmacology·Kjetil AskPhilippe Camus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.